Vaccines are important because they train your immune system to fight specific infections before you ever encounter them, preventing diseases that once killed millions of people every year. Over the past 50 years, global immunization efforts have saved at least 154 million lives, according to the World Health Organization. That works out to roughly six lives saved every minute of every year since widespread vaccination programs began in the 1970s.
How Vaccines Train Your Immune System
When you receive a vaccine, it introduces a harmless piece or weakened version of a pathogen to your body. Your immune system responds by producing two key types of cells. The first are cells that make antibodies, proteins that recognize and neutralize the specific invader. The second are killer cells that destroy infected cells directly. Within about four days of vaccination, antibody-producing cells can increase up to four-fold as your body mounts its initial response.
The real value comes after this first wave subsides. A subset of those activated cells transform into memory cells that persist for months, years, or even decades. These memory cells sit quietly in your lymph nodes, spleen, and bloodstream. If the real pathogen ever shows up, they recognize it immediately and launch a faster, stronger response than your body could mount from scratch. This is why a vaccinated person can fight off an infection before it causes serious illness, or in many cases, before symptoms ever appear.
Diseases Vaccines Have Eliminated or Nearly Wiped Out
The most dramatic success story is smallpox, a disease that killed roughly 300,000 people a year in the United States alone during the 18th century. Because the vaccine was cheap, effective, and the virus only infected humans, health workers could systematically contain every outbreak. Smallpox was declared eradicated worldwide in 1980. No one has needed a smallpox vaccine since, because the virus no longer exists outside of two secure laboratories.
Measles followed a similar trajectory. After an effective vaccine was introduced in 1963, cases in the United States plummeted. Of the 154 million lives saved by vaccines over the past half-century, nearly 94 million were saved by measles vaccines alone. Polio, which once paralyzed tens of thousands of children each year, saw dramatic declines after Jonas Salk’s injectable vaccine arrived in 1955 and Albert Sabin’s oral vaccine followed in 1960. The U.S. has achieved a 100% reduction in cases and deaths for several vaccine-preventable diseases, with substantial decreases for many others.
Protection Beyond Infectious Disease
Vaccines don’t just prevent infections. Some prevent cancer. The HPV vaccine targets strains of human papillomavirus responsible for most cervical cancers. A study from the American Cancer Society found that cervical cancer rates in women ages 20 to 31 dropped by 27% between 2016 and 2021, compared to the period before the vaccine was available. Rates fell from 5.1 to 3.7 per 100,000 women. States with higher HPV vaccination rates saw the largest declines.
Vaccines also play a surprising role in fighting antibiotic resistance. Every time you take antibiotics, bacteria have an opportunity to develop resistance. By preventing infections in the first place, vaccines reduce the need for antibiotics. This applies even to viral vaccines: when you don’t get the flu, you’re less likely to develop a secondary bacterial infection that requires antibiotics, and less likely to receive an unnecessary antibiotic prescription for what turns out to be a viral illness.
How Herd Immunity Protects Vulnerable People
Not everyone can be vaccinated. Newborns, people undergoing chemotherapy, and those with certain immune conditions rely on the people around them being immune. When enough of a population is vaccinated, a disease can’t find enough susceptible hosts to spread, and transmission stalls. This is herd immunity.
The threshold varies by disease. Measles is extremely contagious, so about 95% of a population needs to be vaccinated to stop its spread. Polio requires roughly 80%. When vaccination rates drop below these thresholds, outbreaks return quickly, as communities in several countries have learned in recent years when measles resurged in under-vaccinated populations.
Protecting Newborns Through Maternal Vaccination
Babies are born with immature immune systems that can’t yet respond well to vaccines or infections. To bridge this gap, vaccines given during pregnancy pass protective antibodies through the placenta to the developing baby. These antibodies are present at birth and shield the infant during its most vulnerable first months of life.
The impact is striking. Flu vaccination during pregnancy reduces influenza-related hospitalizations in infants under six months by as much as 72% to 91%, depending on the study. Infants born to mothers who weren’t vaccinated against tetanus, by contrast, have no protection against the disease in their early months. Maternal immunization is now a standard public health strategy specifically because those first weeks carry the highest risk of serious infection.
The Economic Case for Vaccination
Vaccination is one of the highest-return investments in public health. A study examining immunization programs across 94 low- and middle-income countries found that every dollar spent on vaccination against ten common pathogens returned $26.10 in reduced illness costs between 2011 and 2020. When factoring in the broader economic value of lives saved and productivity preserved, the return jumped to $51 per dollar invested.
These numbers reflect not just the cost of treating disease but the ripple effects: parents missing work, children missing school, lifelong disability from preventable complications. Vaccination programs are cheaper than treating outbreaks, and far cheaper than the economic disruption epidemics cause.
How Vaccine Safety Is Monitored
Every vaccine goes through extensive clinical trials before approval, but monitoring doesn’t stop there. In the United States, two major systems track vaccine safety on an ongoing basis. The Vaccine Adverse Event Reporting System collects reports of health problems that occur after vaccination from patients, healthcare providers, and manufacturers. These reports flag potential concerns for further investigation.
The Vaccine Safety Datalink then conducts rigorous studies to determine whether a flagged problem is actually caused by the vaccine or is coincidental. This system links vaccination records with health outcomes across large healthcare organizations, allowing researchers to detect even rare side effects that wouldn’t show up in smaller clinical trials. When new vaccines are licensed or new recommendations are made, both systems ramp up surveillance to catch any unexpected issues early.
Global Coverage and Remaining Gaps
Despite the proven benefits, global vaccination coverage has not fully recovered from disruptions caused by the COVID-19 pandemic. As of 2023, 84% of children worldwide received the basic three-dose series of diphtheria, tetanus, and pertussis vaccine, and 83% received a first dose of measles vaccine. Both figures remain below pre-pandemic levels.
The 101 million infant lives saved over the past 50 years represent what vaccination has accomplished. The gap between 84% coverage and the 95% needed for measles herd immunity represents what remains. In the African Region, vaccination has reduced infant deaths by more than 50%, yet millions of children in low-income countries still miss routine immunizations each year due to limited healthcare access, supply chain challenges, and conflict. Closing that gap is one of the most cost-effective ways to save lives worldwide.